Joey L. Methot

1.8k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Joey L. Methot is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Joey L. Methot has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Genetics. Recurrent topics in Joey L. Methot's work include Chronic Lymphocytic Leukemia Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Biochemical and Molecular Research (3 papers). Joey L. Methot is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Biochemical and Molecular Research (3 papers). Joey L. Methot collaborates with scholars based in United States, Australia and Italy. Joey L. Methot's co-authors include William Roush, Xavier Fradera, Charles A. Lesburg, Mark Bittinger, Zangwei Xu, Brian M. Lacey, Alexander Pasternak, Haiyan Xu, J. Paul Secrist and Nicole Ozerova and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Joey L. Methot

16 papers receiving 1.2k citations

Hit Papers

Nucleophilic Phosphine Organocatalysis 2004 2026 2011 2018 2004 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joey L. Methot United States 12 1.0k 367 312 90 46 17 1.2k
Daniel T. Cohen United States 16 1.2k 1.2× 298 0.8× 185 0.6× 55 0.6× 38 0.8× 20 1.4k
William McCoull United Kingdom 15 1.0k 1.0× 328 0.9× 145 0.5× 49 0.5× 61 1.3× 29 1.2k
Steven H. Spergel United States 16 787 0.8× 281 0.8× 188 0.6× 89 1.0× 27 0.6× 26 1.0k
Andrew Madin United Kingdom 18 815 0.8× 435 1.2× 193 0.6× 45 0.5× 34 0.7× 35 1.1k
Etienne J. Donckèle Switzerland 15 609 0.6× 359 1.0× 133 0.4× 125 1.4× 19 0.4× 21 922
Mathias Frederiksen United States 11 1.0k 1.0× 186 0.5× 318 1.0× 36 0.4× 31 0.7× 19 1.2k
Martyn Inman United Kingdom 12 792 0.8× 233 0.6× 119 0.4× 38 0.4× 38 0.8× 20 1.0k
Anne Mengel Germany 12 623 0.6× 414 1.1× 92 0.3× 88 1.0× 26 0.6× 18 967
Charles W. Johannes Singapore 20 912 0.9× 542 1.5× 145 0.5× 207 2.3× 78 1.7× 44 1.3k
Milan Bruncko United States 14 499 0.5× 433 1.2× 106 0.3× 132 1.5× 37 0.8× 22 884

Countries citing papers authored by Joey L. Methot

Since Specialization
Citations

This map shows the geographic impact of Joey L. Methot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joey L. Methot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joey L. Methot more than expected).

Fields of papers citing papers by Joey L. Methot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joey L. Methot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joey L. Methot. The network helps show where Joey L. Methot may publish in the future.

Co-authorship network of co-authors of Joey L. Methot

This figure shows the co-authorship network connecting the top 25 collaborators of Joey L. Methot. A scholar is included among the top collaborators of Joey L. Methot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joey L. Methot. Joey L. Methot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Methot, Joey L., Matthew J. Mitcheltree, Andrew J. Musacchio, et al.. (2025). The Discovery of Bridged Benzoazepine Amides as Selective Allosteric Modulators of RIPK1. ACS Medicinal Chemistry Letters. 16(5). 811–818.
2.
Liu, Chang, Patrick J. Curran, Matthew Richards, et al.. (2024). High-Throughput Covalent Modifier Screening with Acoustic Ejection Mass Spectrometry. Journal of the American Chemical Society. 146(29). 19792–19799. 8 indexed citations
3.
Methot, Joey L., Xavier Fradera, Charles A. Lesburg, et al.. (2021). Identification of Potent Reverse Indazole Inhibitors for HPK1. ACS Medicinal Chemistry Letters. 12(3). 459–466. 24 indexed citations
4.
Fradera, Xavier, Qiaolin Deng, Solomon D. Kattar, et al.. (2021). Discovery of a new series of PI3K-δ inhibitors from Virtual Screening. Bioorganic & Medicinal Chemistry Letters. 42. 128046–128046. 2 indexed citations
5.
Vara, Brandon, Samuel M. Levi, David A. Candito, et al.. (2021). Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds. ACS Medicinal Chemistry Letters. 12(4). 653–661. 31 indexed citations
6.
Methot, Joey L., Matthew Christopher, Hua Zhou, et al.. (2020). Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors. ACS Medicinal Chemistry Letters. 11(12). 2461–2469. 11 indexed citations
7.
Wang, Yun, Kelvin Zhang, Peter Georgiev, et al.. (2020). Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function. PLoS ONE. 15(12). e0243145–e0243145. 29 indexed citations
8.
McGowan, Meredeth A., Matthew Christopher, Xavier Fradera, et al.. (2019). Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(1). 126715–126715. 11 indexed citations
9.
Fradera, Xavier, Joey L. Methot, Matthew Christopher, et al.. (2019). Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow. Bioorganic & Medicinal Chemistry Letters. 29(18). 2575–2580. 15 indexed citations
10.
McLeod, Robbie L., Dapeng Chen, Antonio Cabal, et al.. (2019). Characterizing Pharmacokinetic–Pharmacodynamic Relationships and Efficacy of PI3Kδ Inhibitors in Respiratory Models of TH2 and TH1 Inflammation. Journal of Pharmacology and Experimental Therapeutics. 369(2). 223–233. 4 indexed citations
11.
Lim, Jongwon, Joey L. Methot, Hua Zhou, et al.. (2016). Discovery of 1-(1H-Pyrazolo[4,3-c]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of Cancers. Journal of Medicinal Chemistry. 59(13). 6501–6511. 25 indexed citations
12.
Newbold, Andrea, Geoffrey M. Matthews, Michael Bots, et al.. (2013). Molecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities. Molecular Cancer Therapeutics. 12(12). 2709–2721. 40 indexed citations
13.
Fischer, Christian, Susan L. Zultanski, Hua Zhou, et al.. (2012). Triazoloamides as potent γ-secretase modulators with reduced hERG liability. Bioorganic & Medicinal Chemistry Letters. 22(9). 3140–3146. 13 indexed citations
14.
Methot, Joey L., Christopher L. Hamblett, Joon Jung, et al.. (2008). SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2). Bioorganic & Medicinal Chemistry Letters. 18(23). 6104–6109. 36 indexed citations
15.
Methot, Joey L., et al.. (2007). An unexpected aminocyclopropane reductive rearrangement. Tetrahedron Letters. 49(7). 1155–1159. 11 indexed citations
16.
Methot, Joey L. & William Roush. (2004). Nucleophilic Phosphine Organocatalysis. Advanced Synthesis & Catalysis. 346(9-10). 1035–1050. 899 indexed citations breakdown →
17.
Methot, Joey L. & William Roush. (2003). Synthetic Studies toward FR182877. Remarkable Solvent Effect in the Vinylogous Morita−Baylis−Hillman Cyclization. Organic Letters. 5(22). 4223–4226. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026